News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Sanofi-Aventis (France) Could Announce Genzyme Corporation Deal Next Week: Report
February 3, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
(Reuters) - French drugmaker Sanofi-Aventis (SASY.PA) could announce a deal to buy U.S. biotech Genzyme (GENZ.O) early next week if final negotiations between the companies go smoothly, Le Figaro reported on Thursday.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Sanofi (France)
MORE ON THIS TOPIC
Alzheimer’s disease
Novartis Makes $1.5B+ Alzheimer’s Play With China’s SciNeuro
January 12, 2026
·
2 min read
·
Tristan Manalac
Lung cancer
Roche Spends $570M on Another ADC Agreement With China’s MediLink
January 9, 2026
·
1 min read
·
Tristan Manalac
Mergers & acquisitions
Revolution Soars Amid Swirling Buyout Rumors With Merck, AbbVie
January 9, 2026
·
1 min read
·
Tristan Manalac
Insights
From Nuclear Winter to Renewal: Biotech Investing for 2026
January 8, 2026
·
1 min read
·
Jennifer Smith-Parker